Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Goa"

759 News Found

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals
Startup | September 24, 2022

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals

The startup plans to provide free technology to dental clinics upon registration.


Glenmark receives OAI from USFDA for Goa facility
News | August 28, 2022

Glenmark receives OAI from USFDA for Goa facility

Glenmark continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest.


Cipla receives 6 observations from USFDA for Goa facility
Drug Approval | August 28, 2022

Cipla receives 6 observations from USFDA for Goa facility

There are no data integrity (DI) observations.


Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv
Digitisation | June 28, 2022

Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv

Strengthens investment in channels of the future to expand patient reach


Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities
News | May 22, 2022

Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities

A total of five observations for Goa and 17 for Monroe


PM Narendra Modi lays down five goals for new WHO Global Centre
News | April 19, 2022

PM Narendra Modi lays down five goals for new WHO Global Centre

Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine


Lupin’s Goa plant receives EIR from US FDA
News | December 14, 2021

Lupin’s Goa plant receives EIR from US FDA

FDA changes inspection classification of the facility to Voluntary Action Indicated


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


U.S. FDA concludes inspection of Lupin’s Goa facility with seven observations
News | September 20, 2021

U.S. FDA concludes inspection of Lupin’s Goa facility with seven observations

The company said in a regulatory filing that it was confident of addressing the observations satisfactorily


Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP
Sustainability | July 31, 2025

Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP

Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant